Status:
COMPLETED
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy
Lead Sponsor:
AstraZeneca
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with painful diabetic polyneuropathy.
Eligibility Criteria
Inclusion
- Provision of signed informed consent form
- Males and female of non-child bearing potential patients aged 18 to 80 years
- Patients with neuropathic pain due to painful diabetic polyneuropathy.
Exclusion
- Other pain that may confound assessment of neuropathic pain
- History of treatment failure with more than three adequate trials of medication for neuropathic pain
- Central neuropathic pain conditions (caused by Central Nervous System injury/disease, eg. Stroke)
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT01201317
Start Date
September 1 2010
End Date
June 1 2011
Last Update
April 25 2014
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Goodyear, Arizona, United States
2
Research Site
Phoenix, Arizona, United States
3
Research Site
Tucson, Arizona, United States
4
Research Site
Los Angeles, California, United States